Market Closed -
Other stock markets
|
After market 16:16:04 | |||
296.4 USD | -1.25% | 299.4 | +1.00% |
05-28 | US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment | RE |
05-28 | Amgen's Rare-Disease Treatment Biosimilar Bkemv Gets FDA Approval | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.93% | 161B | |
+39.22% | 727B | |
+30.57% | 592B | |
-7.85% | 347B | |
+15.48% | 319B | |
-0.12% | 274B | |
+12.55% | 238B | |
+6.65% | 204B | |
-6.09% | 203B | |
-3.37% | 160B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Amgen Inc.: